GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthaverse SA (WAR:SVE) » Definitions » Debt-to-Revenue

Synthaverse (WAR:SVE) Debt-to-Revenue : 1.49 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Synthaverse Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Synthaverse's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was zł18.36 Mil. Synthaverse's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was zł61.58 Mil. Synthaverse's annualized Revenue for the quarter that ended in Sep. 2024 was zł53.63 Mil. Synthaverse's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 1.49.


Synthaverse Debt-to-Revenue Historical Data

The historical data trend for Synthaverse's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthaverse Debt-to-Revenue Chart

Synthaverse Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.33 0.16 0.30 1.20

Synthaverse Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.73 0.87 1.37 1.36 1.49

Competitive Comparison of Synthaverse's Debt-to-Revenue

For the Biotechnology subindustry, Synthaverse's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthaverse's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synthaverse's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Synthaverse's Debt-to-Revenue falls into.



Synthaverse Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Synthaverse's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(8.84 + 61.202) / 58.607
=1.20

Synthaverse's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(18.363 + 61.575) / 53.632
=1.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Synthaverse Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Synthaverse's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthaverse Business Description

Traded in Other Exchanges
N/A
Address
10, Uniwersytecka street, Lublin, POL, 20-029
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.

Synthaverse Headlines

No Headlines